TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06791525: Tirbanibulin for Pediatric Warts

Sponsor: The Skin Center Dermatology Group · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$2,390,400

Rescue Site Savings

+$1,567,040

Unlock Full NCT06791525 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06791525 Rescue Dossier →